Clindamycin palmitate HCl

CAS No. 25507-04-4

Clindamycin palmitate HCl ( —— )

Catalog No. M18316 CAS No. 25507-04-4

Clindamycin palmitate HCl is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid and a lincosamide antibiotic.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 38 Get Quote
100MG 59 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Clindamycin palmitate HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Clindamycin palmitate HCl is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid and a lincosamide antibiotic.
  • Description
    Clindamycin palmitate HCl is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid and a lincosamide antibiotic.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    25507-04-4
  • Formula Weight
    699.85
  • Molecular Formula
    C34H63ClN2O6S·HCl
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)Cl)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bystrzycka W, et al.Cent Eur J Immunol. 2016;41(1):1-5.
molnova catalog
related products
  • A 1120

    A 1120 is a nonretinoid retinol-binding protein 4 (RBP4) antagonist (Ki: 8.3 nM), which disrupts the interaction between RBP4 and its binding partner transthyretin.

  • NSC-41589

    N-[2-(methylsulfanyl) phenyl]acetamide.

  • DCAI

    DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.